ArticleClinical drug investigation2021

Comment on 'Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety'.

Andrew Koren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.